M15 (Potassium Citrate Extended-Release 15 mEq (1620 mg))
Pill with imprint M15 is Yellow, Elliptical/Oval and has been identified as Potassium Citrate Extended-Release 15 mEq (1620 mg).
Potassium citrate is used in the treatment of nephrolithiasis; renal tubular acidosis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 15 mEq (1620 mg) is not a controlled substance under the Controlled Substances Act (CSA).
Images for M15
Potassium Citrate Extended-Release
- Imprint
- M15
- Strength
- 15 mEq (1620 mg)
- Color
- Yellow
- Size
- 20.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Urinary pH modifiers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Manufacturer
- Biocomp Pharma, Inc.
- National Drug Code (NDC)
- 44523-0415
Related images for "M15"
More about potassium citrate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (6)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: urinary pH modifiers
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.